| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 1.12e-08 | 28 | 54 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 3.65e-08 | 35 | 54 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.77e-07 | 153 | 54 | 7 | GO:0008194 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.88e-07 | 48 | 54 | 5 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.08e-07 | 49 | 54 | 5 | GO:0019840 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.55e-06 | 211 | 54 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | helicase activity | 4.21e-06 | 158 | 54 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 7.18e-06 | 2 | 54 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.03e-05 | 107 | 54 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.20e-05 | 288 | 54 | 7 | GO:0016757 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 2.15e-05 | 3 | 54 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | steroid binding | 2.96e-05 | 133 | 54 | 5 | GO:0005496 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 3.04e-05 | 66 | 54 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | fatty acid binding | 3.62e-05 | 69 | 54 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 4.41e-05 | 239 | 54 | 6 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 6.19e-05 | 254 | 54 | 6 | GO:0043177 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 7.25e-05 | 839 | 54 | 10 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 7.32e-05 | 840 | 54 | 10 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 7.32e-05 | 840 | 54 | 10 | GO:0016818 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 1.37e-04 | 97 | 54 | 4 | GO:0008081 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.77e-04 | 441 | 54 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | ADP binding | 2.97e-04 | 48 | 54 | 3 | GO:0043531 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | UGT1A1 PDE2A RAP1GAP ENPP1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 NR6A1 | 3.07e-04 | 815 | 54 | 9 | GO:0042803 |
| GeneOntologyMolecularFunction | protein dimerization activity | UGT1A1 NCOA3 OLIG3 PDE2A RAP1GAP ENPP1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 NR6A1 | 3.20e-04 | 1205 | 54 | 11 | GO:0046983 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.06e-03 | 775 | 54 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 1.10e-03 | 435 | 54 | 6 | GO:0004857 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 1.23e-03 | 78 | 54 | 3 | GO:0003724 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | UGT1A1 WBP11 SH3PXD2B RAP1GAP UGT1A10 UGT1A8 UGT1A7 UGT1A9 PLCD4 SERPIND1 MADD | 1.25e-03 | 1418 | 54 | 11 | GO:0030234 |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.27e-03 | 614 | 54 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 1.33e-03 | 80 | 54 | 3 | GO:0008186 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 1.60e-03 | 22 | 54 | 2 | GO:0004115 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 1.68e-03 | 645 | 54 | 7 | GO:0140640 | |
| GeneOntologyMolecularFunction | DNA polymerase binding | 1.75e-03 | 23 | 54 | 2 | GO:0070182 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 2.07e-03 | 25 | 54 | 2 | GO:0004114 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 2.24e-03 | 26 | 54 | 2 | GO:0004435 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 2.41e-03 | 27 | 54 | 2 | GO:0004112 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 2.66e-03 | 102 | 54 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 2.78e-03 | 29 | 54 | 2 | GO:0004629 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 4.35e-03 | 398 | 54 | 5 | GO:0046982 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.50e-03 | 37 | 54 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.92e-03 | 127 | 54 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 5.28e-03 | 596 | 54 | 6 | GO:0140678 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 5.48e-03 | 262 | 54 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 8.41e-03 | 51 | 54 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 8.92e-03 | 875 | 54 | 7 | GO:0019904 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 9.73e-03 | 55 | 54 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.15e-02 | 60 | 54 | 2 | GO:0034212 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 6.09e-13 | 6 | 54 | 5 | GO:0051552 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.29e-10 | 13 | 54 | 5 | GO:0009812 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 2.09e-10 | 5 | 54 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 2.09e-10 | 5 | 54 | 4 | GO:0052696 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 6.27e-10 | 6 | 54 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 6.27e-10 | 6 | 54 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 2.01e-09 | 21 | 54 | 5 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 6.42e-09 | 26 | 54 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 6.42e-09 | 26 | 54 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 8.71e-09 | 10 | 54 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 8.71e-09 | 10 | 54 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.04e-08 | 12 | 54 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 1.65e-07 | 94 | 54 | 6 | GO:0042440 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.41e-07 | 52 | 54 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 2.43e-07 | 21 | 54 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 1.75e-06 | 222 | 54 | 7 | GO:0071466 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.81e-06 | 141 | 54 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.84e-06 | 34 | 54 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 3.57e-06 | 40 | 54 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | UGT1A1 GLYAT ENPP1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 PTGES3 PGK1 PGK2 | 1.71e-05 | 731 | 54 | 10 | GO:0032787 |
| GeneOntologyBiologicalProcess | secondary metabolic process | 2.85e-05 | 67 | 54 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 6.21e-05 | 525 | 54 | 8 | GO:0009410 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | UGT1A1 GLYAT ENPP1 UGT1A10 UGT1A8 UGT1A7 MTR UGT1A9 PTGES3 PGK1 PGK2 | 6.32e-05 | 1035 | 54 | 11 | GO:0019752 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | UGT1A1 GLYAT ENPP1 UGT1A10 UGT1A8 UGT1A7 MTR UGT1A9 PTGES3 PGK1 PGK2 | 7.70e-05 | 1058 | 54 | 11 | GO:0043436 |
| GeneOntologyBiologicalProcess | purine ribonucleotide catabolic process | 7.96e-05 | 169 | 54 | 5 | GO:0009154 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | UGT1A1 GLYAT ENPP1 UGT1A10 UGT1A8 UGT1A7 MTR UGT1A9 PTGES3 PGK1 PGK2 | 8.10e-05 | 1064 | 54 | 11 | GO:0006082 |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 8.69e-05 | 89 | 54 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | gland development | 9.49e-05 | 558 | 54 | 8 | GO:0048732 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 9.96e-05 | 286 | 54 | 6 | GO:0042445 | |
| GeneOntologyBiologicalProcess | ribonucleotide catabolic process | 1.02e-04 | 178 | 54 | 5 | GO:0009261 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.07e-04 | 94 | 54 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | purine nucleotide catabolic process | 1.13e-04 | 182 | 54 | 5 | GO:0006195 | |
| GeneOntologyBiologicalProcess | purine-containing compound catabolic process | 1.31e-04 | 188 | 54 | 5 | GO:0072523 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.65e-04 | 105 | 54 | 4 | GO:0006721 | |
| GeneOntologyBiologicalProcess | liver development | 1.84e-04 | 202 | 54 | 5 | GO:0001889 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative catabolic process | 1.93e-04 | 323 | 54 | 6 | GO:1901136 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 1.97e-04 | 205 | 54 | 5 | GO:0061008 | |
| GeneOntologyBiologicalProcess | nucleotide catabolic process | 2.10e-04 | 208 | 54 | 5 | GO:0009166 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 2.50e-04 | 117 | 54 | 4 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 2.50e-04 | 117 | 54 | 4 | GO:0009181 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate catabolic process | 2.51e-04 | 216 | 54 | 5 | GO:1901292 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 2.84e-04 | 121 | 54 | 4 | GO:0009191 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 3.12e-04 | 124 | 54 | 4 | GO:0009134 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 3.79e-04 | 684 | 54 | 8 | GO:0010817 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 3.96e-04 | 132 | 54 | 4 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 3.96e-04 | 132 | 54 | 4 | GO:0009179 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 4.35e-04 | 376 | 54 | 6 | GO:0008202 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 5.35e-04 | 143 | 54 | 4 | GO:0009185 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 5.50e-04 | 144 | 54 | 4 | GO:0006720 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 6.25e-04 | 149 | 54 | 4 | GO:0009132 | |
| GeneOntologyBiologicalProcess | organophosphate catabolic process | 8.30e-04 | 281 | 54 | 5 | GO:0046434 | |
| GeneOntologyBiologicalProcess | tetrapyrrole metabolic process | 9.27e-04 | 73 | 54 | 3 | GO:0033013 | |
| GeneOntologyBiologicalProcess | aorta development | 1.21e-03 | 80 | 54 | 3 | GO:0035904 | |
| GeneOntologyBiologicalProcess | NADH regeneration | 1.37e-03 | 21 | 54 | 2 | GO:0006735 | |
| GeneOntologyBiologicalProcess | canonical glycolysis | 1.37e-03 | 21 | 54 | 2 | GO:0061621 | |
| GeneOntologyBiologicalProcess | glucose catabolic process to pyruvate | 1.37e-03 | 21 | 54 | 2 | GO:0061718 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | 1.41e-03 | 646 | 54 | 7 | GO:0005975 | |
| Domain | UDPGT | 3.28e-09 | 21 | 54 | 5 | PF00201 | |
| Domain | UDPGT | 3.28e-09 | 21 | 54 | 5 | PS00375 | |
| Domain | UDP_glucos_trans | 3.28e-09 | 21 | 54 | 5 | IPR002213 | |
| Domain | PGLYCERATE_KINASE | 8.21e-06 | 2 | 54 | 2 | PS00111 | |
| Domain | Phosphoglycerate_kinase_N | 8.21e-06 | 2 | 54 | 2 | IPR015824 | |
| Domain | Phosphoglycerate_kinase_CS | 8.21e-06 | 2 | 54 | 2 | IPR015911 | |
| Domain | Phosphoglycerate_kinase_C | 8.21e-06 | 2 | 54 | 2 | IPR015901 | |
| Domain | - | 8.21e-06 | 2 | 54 | 2 | 3.40.50.1270 | |
| Domain | - | 8.21e-06 | 2 | 54 | 2 | 3.40.50.1260 | |
| Domain | PGK | 8.21e-06 | 2 | 54 | 2 | PF00162 | |
| Domain | Helicase_C | 1.42e-05 | 107 | 54 | 5 | PF00271 | |
| Domain | HELICc | 1.42e-05 | 107 | 54 | 5 | SM00490 | |
| Domain | Helicase_C | 1.49e-05 | 108 | 54 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 1.55e-05 | 109 | 54 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.55e-05 | 109 | 54 | 5 | PS51192 | |
| Domain | DEXDc | 1.55e-05 | 109 | 54 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.63e-05 | 110 | 54 | 5 | IPR014001 | |
| Domain | Phosphoglycerate_kinase | 2.46e-05 | 3 | 54 | 2 | IPR001576 | |
| Domain | BRK | 1.22e-04 | 6 | 54 | 2 | SM00592 | |
| Domain | BRK_domain | 1.22e-04 | 6 | 54 | 2 | IPR006576 | |
| Domain | BRK | 1.22e-04 | 6 | 54 | 2 | PF07533 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.40e-04 | 35 | 54 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 1.79e-04 | 38 | 54 | 3 | PS00690 | |
| Domain | PLipase_C_Pinositol-sp_Y | 8.41e-04 | 15 | 54 | 2 | IPR001711 | |
| Domain | EF-hand_like | 8.41e-04 | 15 | 54 | 2 | PF09279 | |
| Domain | PIPLC_Y_DOMAIN | 8.41e-04 | 15 | 54 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 8.41e-04 | 15 | 54 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 8.41e-04 | 15 | 54 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 8.41e-04 | 15 | 54 | 2 | PF00387 | |
| Domain | PLCYc | 8.41e-04 | 15 | 54 | 2 | SM00149 | |
| Domain | DUF1605 | 1.09e-03 | 17 | 54 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 1.09e-03 | 17 | 54 | 2 | PF07717 | |
| Domain | HA2 | 1.22e-03 | 18 | 54 | 2 | SM00847 | |
| Domain | HA2 | 1.22e-03 | 18 | 54 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 1.22e-03 | 18 | 54 | 2 | IPR007502 | |
| Domain | PI-PLC-X | 1.22e-03 | 18 | 54 | 2 | PF00388 | |
| Domain | PLCXc | 1.22e-03 | 18 | 54 | 2 | SM00148 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.23e-03 | 73 | 54 | 3 | IPR011545 | |
| Domain | DEAD | 1.23e-03 | 73 | 54 | 3 | PF00270 | |
| Domain | - | 1.28e-03 | 746 | 54 | 8 | 3.40.50.300 | |
| Domain | PIPLC_X_DOMAIN | 1.36e-03 | 19 | 54 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 1.36e-03 | 19 | 54 | 2 | IPR000909 | |
| Domain | Chromo_domain | 2.17e-03 | 24 | 54 | 2 | IPR023780 | |
| Domain | - | 2.36e-03 | 25 | 54 | 2 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 2.36e-03 | 25 | 54 | 2 | IPR017946 | |
| Domain | Chromo | 2.55e-03 | 26 | 54 | 2 | PF00385 | |
| Domain | P-loop_NTPase | 2.85e-03 | 848 | 54 | 8 | IPR027417 | |
| Domain | CHROMO_1 | 2.96e-03 | 28 | 54 | 2 | PS00598 | |
| Domain | CHROMO_2 | 2.96e-03 | 28 | 54 | 2 | PS50013 | |
| Domain | SNF2_N | 3.85e-03 | 32 | 54 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 3.85e-03 | 32 | 54 | 2 | IPR016197 | |
| Domain | SNF2_N | 3.85e-03 | 32 | 54 | 2 | PF00176 | |
| Domain | Chromo/shadow_dom | 4.09e-03 | 33 | 54 | 2 | IPR000953 | |
| Domain | CHROMO | 4.09e-03 | 33 | 54 | 2 | SM00298 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.01e-09 | 41 | 42 | 6 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.60e-09 | 45 | 42 | 6 | MM15694 | |
| Pathway | WP_ESTROGEN_METABOLISM | 4.66e-09 | 22 | 42 | 5 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 7.48e-09 | 24 | 42 | 5 | MM14599 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 8.87e-09 | 52 | 42 | 6 | M14171 | |
| Pathway | REACTOME_GLUCURONIDATION | 9.33e-09 | 25 | 42 | 5 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 9.33e-09 | 25 | 42 | 5 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 9.33e-09 | 25 | 42 | 5 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.15e-08 | 26 | 42 | 5 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.71e-08 | 28 | 42 | 5 | M19580 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.58e-08 | 107 | 42 | 7 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.94e-08 | 109 | 42 | 7 | M18788 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 6.67e-08 | 14 | 42 | 4 | M39328 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 9.81e-08 | 39 | 42 | 5 | MM15695 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.83e-07 | 44 | 42 | 5 | M45014 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.24e-07 | 219 | 42 | 8 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.32e-07 | 220 | 42 | 8 | M10320 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 3.90e-07 | 51 | 42 | 5 | M17726 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 5.72e-07 | 55 | 42 | 5 | M14933 | |
| Pathway | REACTOME_DRUG_ADME | 7.78e-07 | 109 | 42 | 6 | M45012 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.23e-06 | 64 | 42 | 5 | M9488 | |
| Pathway | REACTOME_DRUG_ADME | 1.30e-06 | 119 | 42 | 6 | MM15692 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.93e-06 | 70 | 42 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.22e-06 | 72 | 42 | 5 | M9257 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 5.31e-06 | 12 | 42 | 3 | M39611 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 5.63e-06 | 153 | 42 | 6 | MM15844 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 9.28e-06 | 45 | 42 | 4 | M39615 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 6.73e-05 | 145 | 42 | 5 | M45512 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 8.51e-05 | 29 | 42 | 3 | M45015 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 1.15e-04 | 32 | 42 | 3 | M39567 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 2.01e-04 | 183 | 42 | 5 | M39588 | |
| Pathway | KEGG_SPLICEOSOME | 5.40e-04 | 127 | 42 | 4 | M2044 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1 | 1.01e-03 | 16 | 42 | 2 | M47457 | |
| Pathway | WP_CORI_CYCLE | 1.15e-03 | 17 | 42 | 2 | M39604 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 1.29e-03 | 18 | 42 | 2 | M39424 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 1.76e-03 | 21 | 42 | 2 | M39631 | |
| Pathway | WP_MRNA_PROCESSING | 2.05e-03 | 451 | 42 | 6 | MM15946 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 2.29e-03 | 24 | 42 | 2 | M46445 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 2.30e-03 | 314 | 42 | 5 | M39428 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOLYSIS | 2.49e-03 | 25 | 42 | 2 | M47623 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 2.69e-03 | 26 | 42 | 2 | MM15392 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 2.69e-03 | 26 | 42 | 2 | M13748 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 2.90e-03 | 27 | 42 | 2 | M1088 | |
| Pathway | REACTOME_MRNA_SPLICING | 3.56e-03 | 212 | 42 | 4 | M14033 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 3.81e-03 | 31 | 42 | 2 | M39476 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 4.06e-03 | 32 | 42 | 2 | MM14719 | |
| Pubmed | 4.47e-14 | 6 | 54 | 5 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.56e-13 | 7 | 54 | 5 | 8467709 | |
| Pubmed | 1.56e-13 | 7 | 54 | 5 | 8464825 | ||
| Pubmed | 4.16e-13 | 8 | 54 | 5 | 17179145 | ||
| Pubmed | 4.16e-13 | 8 | 54 | 5 | 20610558 | ||
| Pubmed | 4.16e-13 | 8 | 54 | 5 | 18052087 | ||
| Pubmed | 9.36e-13 | 9 | 54 | 5 | 22511988 | ||
| Pubmed | 1.87e-12 | 10 | 54 | 5 | 23642732 | ||
| Pubmed | 1.87e-12 | 10 | 54 | 5 | 11465080 | ||
| Pubmed | 1.87e-12 | 10 | 54 | 5 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.87e-12 | 10 | 54 | 5 | 22558097 | |
| Pubmed | 5.19e-12 | 4 | 54 | 4 | 17558305 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 5.86e-12 | 12 | 54 | 5 | 20308471 | |
| Pubmed | 5.86e-12 | 12 | 54 | 5 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 5.86e-12 | 12 | 54 | 5 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 9.51e-12 | 13 | 54 | 5 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 9.51e-12 | 13 | 54 | 5 | 25246029 | |
| Pubmed | 1.48e-11 | 14 | 54 | 5 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.48e-11 | 14 | 54 | 5 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.48e-11 | 14 | 54 | 5 | 14672974 | |
| Pubmed | 1.48e-11 | 14 | 54 | 5 | 9295054 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 3.22e-11 | 16 | 54 | 5 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 4.55e-11 | 17 | 54 | 5 | 20639394 | |
| Pubmed | 6.30e-11 | 18 | 54 | 5 | 20056724 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 32527940 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 8.53e-11 | 19 | 54 | 5 | 23281178 | |
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 27514509 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 3.10e-10 | 24 | 54 | 5 | 24625756 | |
| Pubmed | 1.70e-09 | 11 | 54 | 4 | 18695635 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 19364970 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 29519853 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 16636344 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 26247833 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 3.54e-09 | 3 | 54 | 3 | 24453052 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 23789755 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 17406868 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 19996319 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 12847094 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 20628391 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 1.41e-08 | 4 | 54 | 3 | 2108603 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 2.92e-08 | 203 | 54 | 7 | 16916647 | |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 2.94e-08 | 57 | 54 | 5 | 21886157 | |
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 3.53e-08 | 5 | 54 | 3 | 18597651 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 20565459 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 15057901 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.07e-08 | 220 | 54 | 7 | 35785414 | |
| Pubmed | 6.21e-08 | 66 | 54 | 5 | 19898482 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 7.05e-08 | 6 | 54 | 3 | 19204906 | |
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 1.97e-07 | 8 | 54 | 3 | 12695355 | |
| Pubmed | 1.97e-07 | 8 | 54 | 3 | 15319294 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 2.95e-07 | 9 | 54 | 3 | 20732626 | |
| Pubmed | 2.95e-07 | 9 | 54 | 3 | 1339448 | ||
| Pubmed | WBP11 PDE2A RAP1GAP VSNL1 EIF4G2 CHD9 ALAD CHD6 PAX6 PTGES3 PGK1 MADD | 5.01e-07 | 1285 | 54 | 12 | 35914814 | |
| Pubmed | Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. | 7.71e-07 | 12 | 54 | 3 | 19349540 | |
| Pubmed | NUDT18 DHX15 LONP1 PDE2A RAP1GAP HNRNPUL2 EIF4G2 HNRNPM PSPC1 PTGES3 PGK1 MADD | 1.55e-06 | 1431 | 54 | 12 | 37142655 | |
| Pubmed | Analysis of the cDNA and encoded protein of the human testis-specific PGK-2 gene. | 2.37e-06 | 2 | 54 | 2 | 9023984 | |
| Pubmed | Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. | 2.37e-06 | 2 | 54 | 2 | 15864130 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 15929176 | ||
| Pubmed | Interethnic Variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population. | 2.37e-06 | 2 | 54 | 2 | 31132973 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 9627603 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 9639672 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 9621515 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 8226884 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 18675828 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 18349289 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 10946897 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 18981166 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 25547628 | ||
| Pubmed | Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. | 2.37e-06 | 2 | 54 | 2 | 7715297 | |
| Pubmed | Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases. | 2.37e-06 | 2 | 54 | 2 | 7989045 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 8706880 | ||
| Pubmed | Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene. | 2.37e-06 | 2 | 54 | 2 | 3453121 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 8441629 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 7906695 | ||
| Pubmed | Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38. | 2.37e-06 | 2 | 54 | 2 | 15286088 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 18454993 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 2298243 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 11901093 | ||
| Pubmed | Selective activation of testis-specific genes in cultured rat spermatogenic cells. | 2.37e-06 | 2 | 54 | 2 | 2166582 | |
| Pubmed | Mapping of a quantitative trait locus for morphine withdrawal severity. | 2.37e-06 | 2 | 54 | 2 | 15457340 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 11677206 | ||
| Pubmed | Human phosphoglycerate kinase. I. Crystallization and characterization of normal enzyme. | 2.37e-06 | 2 | 54 | 2 | 5009693 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 22031623 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 11061796 | ||
| Pubmed | The family of mouse phosphoglycerate kinase genes and pseudogenes. | 2.37e-06 | 2 | 54 | 2 | 2829366 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 18430559 | ||
| Pubmed | Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome. | 2.37e-06 | 2 | 54 | 2 | 12139570 | |
| Pubmed | Characterization of phosphoglycerate kinase from human spermatozoa. | 2.37e-06 | 2 | 54 | 2 | 1278465 | |
| Pubmed | Identification of a putative RNA helicase (HRH1), a human homolog of yeast Prp22. | 2.37e-06 | 2 | 54 | 2 | 7935475 | |
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 2.37e-06 | 2 | 54 | 2 | 10497143 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 18568343 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 8662942 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 2.37e-06 | 2 | 54 | 2 | 17603215 | |
| Pubmed | Influence of UGT1A9 intronic I399C>T polymorphism on SN-38 glucuronidation in Asian cancer patients. | 2.37e-06 | 2 | 54 | 2 | 17700594 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 15709193 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 12944498 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 12402338 | ||
| Pubmed | UGT1A1 and UGT1A9 Are Responsible for Phase II Metabolism of Tectorigenin and Irigenin In Vitro. | 2.37e-06 | 2 | 54 | 2 | 35807350 | |
| Pubmed | NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia. | 2.37e-06 | 2 | 54 | 2 | 17805331 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 9647757 | ||
| Interaction | MORC2 interactions | 4.46e-06 | 91 | 54 | 5 | int:MORC2 | |
| Interaction | UGT1A9 interactions | 5.10e-06 | 13 | 54 | 3 | int:UGT1A9 | |
| Interaction | UGT1A7 interactions | 1.64e-05 | 57 | 54 | 4 | int:UGT1A7 | |
| Interaction | UGT1A8 interactions | 2.11e-05 | 3 | 54 | 2 | int:UGT1A8 | |
| Interaction | SMAD3 interactions | 2.34e-05 | 447 | 54 | 8 | int:SMAD3 | |
| Interaction | FOXC1 interactions | 3.22e-05 | 228 | 54 | 6 | int:FOXC1 | |
| Interaction | NXPH2 interactions | 9.37e-05 | 33 | 54 | 3 | int:NXPH2 | |
| Interaction | UGT1A10 interactions | 9.37e-05 | 33 | 54 | 3 | int:UGT1A10 | |
| Cytoband | 2q37 | 3.09e-10 | 31 | 54 | 5 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 7.19e-06 | 226 | 54 | 5 | chr2q37 | |
| Cytoband | 20q12 | 3.69e-04 | 24 | 54 | 2 | 20q12 | |
| GeneFamily | UDP glucuronosyltransferases | 5.24e-09 | 32 | 37 | 5 | 363 | |
| GeneFamily | DEAH-box helicases | 4.80e-04 | 16 | 37 | 2 | 500 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.44e-04 | 17 | 37 | 2 | 486 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 6.82e-04 | 19 | 37 | 2 | 832 | |
| GeneFamily | EF-hand domain containing | 1.01e-02 | 219 | 37 | 3 | 863 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_500 | 1.13e-05 | 118 | 53 | 5 | gudmap_developingGonad_e14.5_ ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 1.88e-05 | 776 | 53 | 10 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-06 | 171 | 53 | 5 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.26e-06 | 192 | 53 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.35e-06 | 193 | 53 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.52e-06 | 195 | 53 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.55e-05 | 166 | 53 | 4 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.10e-05 | 171 | 53 | 4 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-05 | 181 | 53 | 4 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-05 | 181 | 53 | 4 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.07e-05 | 186 | 53 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.07e-05 | 186 | 53 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.22e-05 | 187 | 53 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 8.32e-05 | 194 | 53 | 4 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.49e-05 | 195 | 53 | 4 | d8fa96c8f14bd088c3f8bd14f894a2c5b7ad46a7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-05 | 195 | 53 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-05 | 195 | 53 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.49e-05 | 195 | 53 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-05 | 196 | 53 | 4 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.65e-05 | 196 | 53 | 4 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.65e-05 | 196 | 53 | 4 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| Computational | Neighborhood of RPA1 | 1.07e-04 | 28 | 36 | 3 | GNF2_RPA1 | |
| Computational | Neighborhood of TDG | 2.10e-04 | 35 | 36 | 3 | GNF2_TDG | |
| Computational | Genes in the cancer module 284. | 4.44e-04 | 45 | 36 | 3 | MODULE_284 | |
| Drug | naringenin chalcone | 6.21e-14 | 5 | 54 | 5 | ctd:C027329 | |
| Drug | anthrarobin | 6.21e-14 | 5 | 54 | 5 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 3.72e-13 | 6 | 54 | 5 | ctd:C543211 | |
| Drug | alloin | 3.72e-13 | 6 | 54 | 5 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 3.72e-13 | 6 | 54 | 5 | ctd:C107497 | |
| Drug | 2',4'-dihydroxychalcone | 1.30e-12 | 7 | 54 | 5 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 3.46e-12 | 8 | 54 | 5 | ctd:C034890 | |
| Drug | AC1MRQNQ | 7.76e-12 | 9 | 54 | 5 | CID003522271 | |
| Drug | DHPASiU | 7.76e-12 | 9 | 54 | 5 | CID000197602 | |
| Drug | Chebi:32663 | 7.76e-12 | 9 | 54 | 5 | CID005460873 | |
| Drug | 3-iodophenol | 7.76e-12 | 9 | 54 | 5 | CID000012272 | |
| Drug | AC1L4J7U | 7.76e-12 | 9 | 54 | 5 | CID000186631 | |
| Drug | 2,6-dihydroxyanthraquinone | 1.55e-11 | 10 | 54 | 5 | ctd:C034889 | |
| Drug | 4-nitrophenyl)imidazole | 2.84e-11 | 11 | 54 | 5 | CID000123155 | |
| Drug | AC1O5XMV | 2.84e-11 | 11 | 54 | 5 | CID006442661 | |
| Drug | N-OH-DABZ | 4.85e-11 | 12 | 54 | 5 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 4.85e-11 | 12 | 54 | 5 | CID000088735 | |
| Drug | 4-hydroxyestrone | 4.85e-11 | 12 | 54 | 5 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 4.85e-11 | 12 | 54 | 5 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 4.85e-11 | 12 | 54 | 5 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 4.85e-11 | 12 | 54 | 5 | CID000160090 | |
| Drug | 2-hydroxyestrone | 7.87e-11 | 13 | 54 | 5 | ctd:C024980 | |
| Drug | tritanol | 7.87e-11 | 13 | 54 | 5 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 7.87e-11 | 13 | 54 | 5 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 7.87e-11 | 13 | 54 | 5 | CID000000411 | |
| Drug | alizarin | 7.87e-11 | 13 | 54 | 5 | ctd:C010078 | |
| Drug | propranolol glucuronide | 1.22e-10 | 14 | 54 | 5 | CID000119515 | |
| Drug | PCB-61 | 1.22e-10 | 14 | 54 | 5 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.83e-10 | 15 | 54 | 5 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 1.83e-10 | 15 | 54 | 5 | CID000010752 | |
| Drug | bergamottin | 1.83e-10 | 15 | 54 | 5 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 1.83e-10 | 15 | 54 | 5 | CID000543743 | |
| Drug | afloqualone | 1.83e-10 | 15 | 54 | 5 | CID000002040 | |
| Drug | naphthyl sulphate | 1.83e-10 | 15 | 54 | 5 | CID000114775 | |
| Drug | quercetin-3,4'-diglucoside | 2.66e-10 | 16 | 54 | 5 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 2.66e-10 | 16 | 54 | 5 | CID000040003 | |
| Drug | bilirubin-phosphate | 2.66e-10 | 16 | 54 | 5 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 3.76e-10 | 17 | 54 | 5 | CID000003573 | |
| Drug | 6-hydroxychrysene | 3.76e-10 | 17 | 54 | 5 | CID000037766 | |
| Drug | thymoquinone | 4.82e-10 | 40 | 54 | 6 | CID000010281 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 5.19e-10 | 18 | 54 | 5 | CID000152226 | |
| Drug | Br 2 | 5.19e-10 | 18 | 54 | 5 | CID003060900 | |
| Drug | SureCN12722713 | 5.19e-10 | 18 | 54 | 5 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 5.19e-10 | 18 | 54 | 5 | CID000036614 | |
| Drug | ApApG | 5.19e-10 | 18 | 54 | 5 | CID003081975 | |
| Drug | C1 11-32 | 5.19e-10 | 18 | 54 | 5 | CID000443077 | |
| Drug | C11131 | 5.19e-10 | 18 | 54 | 5 | CID000443076 | |
| Drug | L 654969 | 6.57e-10 | 42 | 54 | 6 | CID000005218 | |
| Drug | almokalant | 7.04e-10 | 19 | 54 | 5 | CID003033962 | |
| Drug | 9-OH-risperidone | 7.04e-10 | 19 | 54 | 5 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 7.04e-10 | 19 | 54 | 5 | CID000091433 | |
| Drug | tectochrysin | 9.37e-10 | 20 | 54 | 5 | CID005281954 | |
| Drug | AC1L1OBF | 9.37e-10 | 20 | 54 | 5 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 9.37e-10 | 20 | 54 | 5 | CID000116545 | |
| Drug | entacapone | 9.37e-10 | 20 | 54 | 5 | ctd:C071192 | |
| Drug | estriol-16-glucuronide | 1.23e-09 | 21 | 54 | 5 | CID000122281 | |
| Drug | dulcin | 1.23e-09 | 21 | 54 | 5 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.23e-09 | 21 | 54 | 5 | CID000069186 | |
| Drug | amonafide | 1.59e-09 | 22 | 54 | 5 | CID000050515 | |
| Drug | plumbagin | 1.59e-09 | 22 | 54 | 5 | ctd:C014758 | |
| Drug | N-methylpiperazine | 1.59e-09 | 22 | 54 | 5 | CID000053167 | |
| Drug | EM-652 | 1.73e-09 | 49 | 54 | 6 | CID000155435 | |
| Drug | glabridin | 1.96e-09 | 8 | 54 | 4 | ctd:C107601 | |
| Drug | amidoxime | 2.02e-09 | 23 | 54 | 5 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 2.02e-09 | 23 | 54 | 5 | CID000066651 | |
| Drug | phenanthridine | 2.02e-09 | 23 | 54 | 5 | CID000009189 | |
| Drug | AS-3201 | 2.55e-09 | 24 | 54 | 5 | CID000153948 | |
| Drug | 5-MOP | 3.18e-09 | 25 | 54 | 5 | CID000002355 | |
| Drug | Hymecromone | 3.18e-09 | 25 | 54 | 5 | ctd:D006923 | |
| Drug | AzMC | 3.18e-09 | 25 | 54 | 5 | CID000064986 | |
| Drug | N-acetylbenzidine | 3.18e-09 | 25 | 54 | 5 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 3.18e-09 | 25 | 54 | 5 | CID000006796 | |
| Drug | N-phenylmaleimide | 3.18e-09 | 25 | 54 | 5 | CID000013662 | |
| Drug | Thymol | 3.93e-09 | 26 | 54 | 5 | ctd:D013943 | |
| Drug | Invader | 3.96e-09 | 56 | 54 | 6 | CID006442259 | |
| Drug | Scopoletin | 4.82e-09 | 27 | 54 | 5 | ctd:D012603 | |
| Drug | DiMeIQx | 4.82e-09 | 27 | 54 | 5 | CID000104739 | |
| Drug | licochalcone A | 4.82e-09 | 27 | 54 | 5 | ctd:C070840 | |
| Drug | diflunisal | 4.82e-09 | 27 | 54 | 5 | CID000003059 | |
| Drug | N-hydroxy-4-aminobiphenyl | 5.85e-09 | 28 | 54 | 5 | CID000081261 | |
| Drug | CARMINE | 5.85e-09 | 28 | 54 | 5 | CID000014749 | |
| Drug | erucin | 5.85e-09 | 28 | 54 | 5 | CID000078160 | |
| Drug | H-Ni | 5.85e-09 | 28 | 54 | 5 | CID000445665 | |
| Drug | Glucuronides | 5.87e-09 | 10 | 54 | 4 | ctd:D020719 | |
| Drug | 3-OH | 6.71e-09 | 61 | 54 | 6 | CID000068152 | |
| Drug | AC1L1JAL | 7.06e-09 | 29 | 54 | 5 | CID000004954 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 7.06e-09 | 29 | 54 | 5 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 7.06e-09 | 29 | 54 | 5 | CID000000414 | |
| Drug | 7-hydroxycoumarin glucuronide | 7.06e-09 | 29 | 54 | 5 | CID000125641 | |
| Drug | iberin | 7.06e-09 | 29 | 54 | 5 | CID000010455 | |
| Drug | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 7.06e-09 | 29 | 54 | 5 | ctd:C060533 | |
| Drug | Estrone | 8.44e-09 | 112 | 54 | 7 | ctd:D004970 | |
| Drug | tolcapone | 8.46e-09 | 30 | 54 | 5 | CID004659569 | |
| Drug | paricalcitol | 8.46e-09 | 30 | 54 | 5 | CID005281104 | |
| Drug | AC1L9E0Q | 8.46e-09 | 30 | 54 | 5 | CID000443095 | |
| Drug | dihydroartemisinin | 8.46e-09 | 30 | 54 | 5 | CID000107770 | |
| Drug | 4-ethylphenol | 1.01e-08 | 31 | 54 | 5 | CID000031242 | |
| Drug | PCB 156 | 1.01e-08 | 31 | 54 | 5 | CID000038019 | |
| Drug | 4'-HPPH | 1.01e-08 | 31 | 54 | 5 | CID000017732 | |
| Drug | indole-2-carboxylic acid | 1.19e-08 | 32 | 54 | 5 | CID000072899 | |
| Disease | X-11442 measurement | 1.75e-12 | 9 | 52 | 5 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.75e-12 | 9 | 52 | 5 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.75e-12 | 9 | 52 | 5 | EFO_0004739 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.75e-12 | 9 | 52 | 5 | EFO_0004570, GO_0009410 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 3.49e-12 | 10 | 52 | 5 | EFO_0802185 | |
| Disease | bilirubin measurement, response to tenofovir | 3.49e-12 | 10 | 52 | 5 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 6.39e-12 | 11 | 52 | 5 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 6.39e-12 | 11 | 52 | 5 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 6.39e-12 | 11 | 52 | 5 | EFO_0800972 | |
| Disease | aldosterone measurement | 6.39e-12 | 11 | 52 | 5 | EFO_0010219 | |
| Disease | biliverdin measurement | 1.09e-11 | 12 | 52 | 5 | EFO_0021033 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 4.28e-11 | 5 | 52 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 4.28e-11 | 5 | 52 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 4.28e-11 | 5 | 52 | 4 | EFO_0801853 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 8.49e-11 | 17 | 52 | 5 | EFO_0004611, EFO_0007800 | |
| Disease | X-21339 measurement | 2.99e-10 | 7 | 52 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 5.97e-10 | 8 | 52 | 4 | EFO_0800766 | |
| Disease | urate measurement, spine bone mineral density | 8.39e-10 | 58 | 52 | 6 | EFO_0004531, EFO_0007701 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.07e-09 | 9 | 52 | 4 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.07e-09 | 9 | 52 | 4 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.07e-09 | 9 | 52 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.07e-09 | 9 | 52 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.07e-09 | 9 | 52 | 4 | EFO_0020691 | |
| Disease | xanthurenate measurement | 1.60e-09 | 29 | 52 | 5 | EFO_0010551 | |
| Disease | X-21448 measurement | 1.79e-09 | 10 | 52 | 4 | EFO_0800816 | |
| Disease | X-23974 measurement | 1.79e-09 | 10 | 52 | 4 | EFO_0800867 | |
| Disease | response to dolutegravir | 1.92e-09 | 30 | 52 | 5 | EFO_0600017 | |
| Disease | pregnenetriol sulfate measurement | 2.80e-09 | 11 | 52 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 2.80e-09 | 11 | 52 | 4 | EFO_0600039 | |
| Disease | p-cresol glucuronide measurement | 4.20e-09 | 12 | 52 | 4 | EFO_0800079 | |
| Disease | blood 4-oxo-retinoic acid measurement | 5.16e-09 | 3 | 52 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 5.16e-09 | 3 | 52 | 3 | EFO_0800043 | |
| Disease | retinol dehydrogenase 16 measurement | 6.06e-09 | 13 | 52 | 4 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 6.06e-09 | 13 | 52 | 4 | EFO_0800587 | |
| Disease | X-21441 measurement | 2.01e-08 | 17 | 52 | 4 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 2.58e-08 | 18 | 52 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 5.02e-08 | 21 | 52 | 4 | EFO_0010623 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.03e-07 | 6 | 52 | 3 | EFO_0800566 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.70e-07 | 28 | 52 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.33e-07 | 147 | 52 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | thyroxine measurement | 3.65e-07 | 83 | 52 | 5 | EFO_0005130 | |
| Disease | cholelithiasis | 4.89e-07 | 88 | 52 | 5 | EFO_0004799 | |
| Disease | vitamin D deficiency | 5.42e-07 | 37 | 52 | 4 | EFO_0003762 | |
| Disease | indoleacetate measurement | 6.14e-07 | 10 | 52 | 3 | EFO_0021015 | |
| Disease | dodecanedioate measurement | 1.12e-06 | 12 | 52 | 3 | EFO_0021054 | |
| Disease | gallstones | 1.36e-06 | 108 | 52 | 5 | EFO_0004210 | |
| Disease | X-24588 measurement | 1.46e-06 | 13 | 52 | 3 | EFO_0800898 | |
| Disease | vitamin D measurement, COVID-19 | 1.71e-06 | 49 | 52 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | urate measurement, bone density | 1.20e-05 | 619 | 52 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | hormone measurement | 1.49e-05 | 84 | 52 | 4 | EFO_0004730 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 6.36e-05 | 7 | 52 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Hematological Disease | 8.47e-05 | 8 | 52 | 2 | C0018939 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.85e-04 | 914 | 52 | 8 | EFO_0004532 | |
| Disease | serum metabolite measurement | 2.32e-04 | 945 | 52 | 8 | EFO_0005653 | |
| Disease | respiratory symptom change measurement, response to placebo | 4.07e-04 | 17 | 52 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | ischemia (implicated_via_orthology) | 4.07e-04 | 17 | 52 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | free androgen index | 5.08e-04 | 374 | 52 | 5 | EFO_0007005 | |
| Disease | Malignant neoplasm of breast | 5.45e-04 | 1074 | 52 | 8 | C0006142 | |
| Disease | otitis media (implicated_via_orthology) | 6.88e-04 | 22 | 52 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | cup-to-disc ratio measurement | 9.50e-04 | 430 | 52 | 5 | EFO_0006939 | |
| Disease | bilirubin measurement | 1.07e-03 | 442 | 52 | 5 | EFO_0004570 | |
| Disease | cancer (implicated_via_orthology) | 1.28e-03 | 268 | 52 | 4 | DOID:162 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DEADRMLDMGFGPEM | 446 | Q9NQI0 | |
| PGMNRTDDMMVPDQR | 1561 | Q8NFD5 | |
| MTDGMLLREAMNDPL | 236 | O43143 | |
| MKGPIDINMSEIGMD | 121 | O43286 | |
| NMLDKVNEMIIGGGM | 226 | P07205 | |
| LMGIRMLFDKNGNMA | 411 | P05546 | |
| QMGADGMYDKLRMLN | 136 | P26367 | |
| YIMKEDPGAGRLQMM | 2116 | Q86XX4 | |
| AVMLEREGMGMDQGP | 1331 | Q8WXG6 | |
| REGMGMDQGPQEMID | 1336 | Q8WXG6 | |
| LDPMEQRGGMKMAVL | 221 | Q6ZVK8 | |
| DVREGADMLMVKPGM | 241 | P13716 | |
| LMDQTGEMRMAGTLP | 221 | Q6IB77 | |
| MMNGMKLSGREIDVR | 711 | P52272 | |
| LEKAMGNRPMEMMDR | 836 | O00408 | |
| DRMHRNKRGNMPPME | 351 | Q1MSJ5 | |
| NQMRMKGLEEPEMDP | 491 | Q1KMD3 | |
| EMQDLGDKLRMIVMG | 196 | P36776 | |
| KALQRVDGMVGMLMD | 391 | P22413 | |
| MTGELEVKNMDMKPG | 1 | P05162 | |
| NMLDKVNEMIIGGGM | 226 | P00558 | |
| MKMDRDPLGGLADMF | 361 | P78344 | |
| DMMQKMPGESLSRAG | 46 | Q7RTU3 | |
| DMIQMFQVPSMGGRK | 351 | Q0D2I5 | |
| LAVQRGMNMGVNLMP | 1891 | Q92794 | |
| EVDGSQGNMMRMGPK | 1706 | Q8NFC6 | |
| QGNMMRMGPKKETEG | 1711 | Q8NFC6 | |
| GGEAKNMAAMFPMLL | 2701 | Q3L8U1 | |
| MDLVGLQNMRNMPGI | 2476 | Q8TD26 | |
| RMDMPGLVNLMKENF | 26 | Q5SY68 | |
| IAANMRGIGMMPNDI | 521 | Q14562 | |
| RMGNLGLQMEAENRM | 606 | Q12889 | |
| LQMGMNRKAIREDGM | 121 | Q15406 | |
| TDQDLLLMQEGMPMR | 11 | Q9BRC7 | |
| EMSQRMGKENMEQPN | 591 | Q9UPR0 | |
| PMKLNKEMVEGMGGT | 776 | Q8NEB9 | |
| NMDDGMLDGPSAMTR | 416 | Q99707 | |
| KAGRMEPMNSNSMGR | 926 | Q9Y6Q9 | |
| DAEGDPLMNMLMRLQ | 2441 | Q8IVL1 | |
| QSMMGLGGDEDKMEN | 406 | P47736 | |
| VMMPLFGDQMDNAKR | 386 | Q9HAW8 | |
| IMMKMNEDGLTPEQR | 136 | P62760 | |
| MDPKMDAGMIGNQVN | 66 | Q5VZE5 | |
| PLDMIKSRMQMDGLR | 221 | Q8N413 | |
| MMNNMGGDEDVDLPE | 126 | Q15185 | |
| NREQEMRMGDMGPRG | 386 | Q8WXF1 | |
| EMQGAMGMEPLHRKA | 781 | Q8TEJ3 | |
| LQMQMLDKFPMEGGQ | 51 | A1X283 | |
| MPLFGDQMDNAKRME | 391 | P22309 | |
| VMMPLFGDQMDNAKR | 386 | O60656 | |
| MLDNRKMGDMPEING | 96 | Q9NZI7 | |
| MMNGLRNLGINGEDM | 406 | Q9NYU1 | |
| QAMMLRMAGQEIPEE | 331 | Q9Y2W2 | |
| VMMPLFGDQMDNAKR | 386 | Q9HAW7 | |
| MGEELMMEHPGLQAI | 581 | O43156 | |
| VMMPLFGDQMDNAKR | 386 | Q9HAW9 |